Drug
Potassium Acetate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Atelectasis | 14 | 21.1 | 21.3 | signal |
| 2 | Mitral Valve Incompetence | 14 | 18.1 | 18.2 | signal |
| 3 | Pharmaceutical Product Complaint | 25 | 13.9 | 14.1 | signal |
| 4 | Anorexia | 12 | 13.4 | 13.5 | signal |
| 5 | Pulmonary Congestion | 12 | 13.2 | 13.3 | signal |
| 6 | Blood Potassium Decreased | 27 | 13.1 | 13.3 | signal |
| 7 | Economic Problem | 13 | 12.3 | 12.4 | signal |
| 8 | Blood Potassium Increased | 13 | 11.7 | 11.8 | signal |
| 9 | Laceration | 7 | 10.7 | 10.8 | signal |
| 10 | Hypoaesthesia Oral | 11 | 10.7 | 10.7 | signal |
| 11 | Coronary Artery Occlusion | 10 | 10.6 | 10.7 | signal |
| 12 | Malnutrition | 8 | 10.5 | 10.6 | signal |
| 13 | Restless Legs Syndrome | 13 | 10.4 | 10.5 | signal |
| 14 | Pulmonary Hypertension | 14 | 9.8 | 9.9 | signal |
| 15 | Cardiomegaly | 8 | 9.4 | 9.5 | signal |
| 16 | Blood Sodium Decreased | 12 | 9.3 | 9.4 | signal |
| 17 | Cholecystectomy | 7 | 9.0 | 9.0 | signal |
| 18 | Cardiomyopathy | 9 | 8.9 | 8.9 | signal |
| 19 | Body Height Decreased | 6 | 8.1 | 8.1 | signal |
| 20 | Brain Oedema | 7 | 8.1 | 8.1 | signal |
| 21 | Ejection Fraction Decreased | 8 | 7.5 | 7.5 | signal |
| 22 | Gallbladder Disorder | 9 | 7.3 | 7.4 | signal |
| 23 | Spinal Fracture | 10 | 7.3 | 7.4 | signal |
| 24 | Bronchospasm | 7 | 7.1 | 7.2 | signal |
| 25 | Middle Insomnia | 9 | 7.1 | 7.1 | signal |
| 26 | Fluid Overload | 7 | 6.9 | 7.0 | signal |
| 27 | Cytokine Release Syndrome | 9 | 6.9 | 6.9 | signal |
| 28 | Coronary Artery Disease | 14 | 6.7 | 6.8 | signal |
| 29 | Blood Glucose Decreased | 22 | 6.7 | 6.8 | signal |
| 30 | Cardiac Failure Congestive | 34 | 6.1 | 6.2 | signal |
| 31 | Face Oedema | 7 | 6.0 | 6.1 | signal |
| 32 | Neurotoxicity | 7 | 5.9 | 5.9 | signal |
| 33 | Multi-organ Failure | 7 | 5.8 | 5.8 | signal |
| 34 | Therapy Partial Responder | 6 | 5.8 | 5.8 | signal |
| 35 | Fluid Retention | 20 | 5.7 | 5.8 | signal |
| 36 | Eructation | 7 | 5.4 | 5.4 | signal |
| 37 | Bipolar Disorder | 4 | 5.3 | 5.3 | signal |
| 38 | Drug Toxicity | 5 | 5.3 | 5.3 | signal |
| 39 | Cytopenia | 4 | 4.9 | 4.9 | signal |
| 40 | Emotional Disorder | 10 | 4.7 | 4.7 | signal |
| 41 | Mydriasis | 4 | 4.6 | 4.6 | signal |
| 42 | Convulsion | 18 | 4.5 | 4.6 | signal |
| 43 | Bone Marrow Failure | 6 | 4.3 | 4.3 | signal |
| 44 | Diabetes Mellitus Inadequate Control | 5 | 4.1 | 4.1 | signal |
| 45 | Abasia | 7 | 4.1 | 4.1 | signal |
| 46 | Blood Glucose Increased | 50 | 3.9 | 4.0 | signal |
| 47 | Libido Decreased | 3 | 3.5 | 3.5 | no signal |
| 48 | Hair Texture Abnormal | 3 | 3.2 | 3.2 | no signal |
| 49 | Osteonecrosis Of Jaw | 5 | 2.9 | 2.9 | signal |
| 50 | Tardive Dyskinesia | 5 | 2.6 | 2.6 | no signal |
| 51 | Injection Site Rash | 4 | 1.9 | 1.9 | no signal |
| 52 | Application Site Erythema | 3 | 1.7 | 1.7 | no signal |
| 53 | Product Adhesion Issue | 3 | 1.2 | 1.2 | no signal |